44 Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$702K Sell
4,823
-838
-15% -$114K 0.24% 87
2023
Q1
$731K Sell
5,661
-816
-13% -$102K 0.25% 88
2022
Q4
$826K Buy
6,477
+1,596
+33% +$185K 0.29% 82
2022
Q3
$510K Sell
4,881
-100
-2% -$11K 0.21% 101
2022
Q2
$523K Buy
4,981
+34
+0.7% +$4.03K 0.2% 102
2022
Q1
$633K Buy
4,947
+15
+0.3% +$1.81K 0.23% 100
2021
Q4
$608K Buy
4,932
+512
+12% +$67K 0.21% 96
2021
Q3
$628K Sell
4,420
-11
-0.2% -$1.62K 0.24% 91
2021
Q2
$692K Buy
4,431
+655
+17% +$106K 0.27% 86
2021
Q1
$587K Buy
+3,776
New +$585K 0.25% 90

Other funds holding ZBH

44 Wealth Management's ZBH Position: Q2 2023 in Review

44 Wealth Management reduced its Zimmer Biomet (ZBH) stake by 15% in Q2 2023, selling an estimated $114K and leaving 4,823 shares worth $702K. The position accounts for 0.24% of the portfolio, ranked #87.

44 Wealth Management first reported a position in ZBH in Q1 2021 and has held it in 10 quarters since. The position peaked at $826K in Q4 2022. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • 44 Wealth Management held 4,823 shares of Zimmer Biomet worth $702K as of Q2 2023.
  • 44 Wealth Management sold 838 Zimmer Biomet shares in Q2 2023, an estimated $114K.
  • Zimmer Biomet made up 0.24% of 44 Wealth Management's portfolio in Q2 2023, its #87 holding.
  • 44 Wealth Management first reported a position in Zimmer Biomet in Q1 2021 and has held it in 10 quarters since.
  • 44 Wealth Management's Zimmer Biomet position peaked at $826K in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on 44 Wealth Management's 13F filing for Q2 2023, filed 18 Jul 2023.